Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6529
    +0.0029 (+0.45%)
     
  • OIL

    82.88
    +0.07 (+0.08%)
     
  • GOLD

    2,339.80
    +1.40 (+0.06%)
     
  • Bitcoin AUD

    98,234.46
    -3,511.83 (-3.45%)
     
  • CMC Crypto 200

    1,361.14
    -21.43 (-1.55%)
     
  • AUD/EUR

    0.6086
    +0.0016 (+0.26%)
     
  • AUD/NZD

    1.0951
    +0.0009 (+0.08%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,090.86
    +50.48 (+0.63%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,991.57
    -97.13 (-0.54%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Johnson & Johnson Rises on Q4 Beats, Coronavirus Vaccine Hopes

Johnson & Johnson Rises on Q4 Beats, Coronavirus Vaccine Hopes

Johnson & Johnson (NYSE: JNJ) delivered an encouraging set of quarterly results on Tuesday, which included a promising -- albeit limited -- update on its coronavirus vaccine candidate. For the sprawling company's fourth quarter of fiscal 2020, revenue came in at just under $22.